HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chella S David Selected Research

HLA-DQ8 antigen

1/2014HLA class II (DR0401) molecules induce Foxp3+ regulatory T cell suppression of B cells in Plasmodium yoelii strain 17XNL malaria.
1/2014The impact of Staphylococcus aureus-associated molecular patterns on staphylococcal superantigen-induced toxic shock syndrome and pneumonia.
11/2008The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease.
5/2007Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans.
4/2007B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice.
2/2006Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.
12/2005Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization.
12/2005HLA-DQ8 is a predisposing molecule for detergent enzyme subtilisin BPN'-induced hypersensitivity.
1/2005Requirement for CD28 may not be absolute for collagen-induced arthritis: study with HLA-DQ8 transgenic mice.
6/2004Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chella S David Research Topics

Disease

13Infections
10/2017 - 08/2002
11Septic Shock (Toxic Shock Syndrome)
10/2017 - 11/2004
11Arthritis (Polyarthritis)
11/2014 - 06/2002
11Inflammation (Inflammations)
01/2014 - 02/2003
9Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
02/2016 - 04/2002
8Thyroiditis
02/2016 - 04/2002
7Autoimmune Diseases (Autoimmune Disease)
01/2017 - 12/2003
6Experimental Arthritis
11/2014 - 10/2003
6Multiple Sclerosis
06/2012 - 04/2003
6Demyelinating Diseases (Demyelinating Disease)
02/2012 - 08/2002
6Celiac Disease (Celiac Sprue)
02/2012 - 11/2002
5Genetic Predisposition to Disease (Genetic Predisposition)
11/2015 - 12/2005
5Rheumatoid Arthritis
11/2014 - 04/2004
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2011 - 11/2002
5Shock
06/2010 - 07/2002
4Pneumonia (Pneumonitis)
10/2017 - 02/2003
4Graves Disease (Basedow Disease)
09/2011 - 09/2003
4Asthma (Bronchial Asthma)
09/2007 - 01/2002
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2015 - 01/2010
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2012 - 04/2005
3Disease Susceptibility (Diathesis)
02/2012 - 12/2008
3Virus Diseases (Viral Diseases)
02/2012 - 02/2006
3Neoplasms (Cancer)
06/2010 - 07/2007
3Hypersensitivity (Allergy)
08/2009 - 12/2005
2Thyroid Diseases (Thyroid Disease)
02/2016 - 09/2011
2Lymphocytosis
10/2011 - 02/2003
2Uveitis
08/2011 - 04/2003
2Hyperthyroidism
10/2007 - 12/2006
1Wounds and Injuries (Trauma)
12/2015
1Wound Infection (Wound Infections)
12/2015
1Glomerulonephritis
11/2015
1Lupus Nephritis
11/2015
1Bacteremia
08/2015
1Endocarditis
06/2014

Drug/Important Bio-Agent (IBA)

18Peptides (Polypeptides)IBA
02/2016 - 08/2002
16AntigensIBA
11/2014 - 04/2003
16HLA-DQ8 antigenIBA
01/2014 - 01/2002
15SuperantigensIBA
10/2017 - 11/2004
14CytokinesIBA
01/2013 - 08/2002
13HLA-DR3 Antigen (HLA DR3 Antigen)IBA
10/2017 - 11/2002
10EpitopesIBA
09/2011 - 02/2003
9HLA-DR Antigens (HLA-DR)IBA
02/2016 - 04/2002
8ThyroglobulinFDA Link
09/2011 - 04/2002
6AntibodiesIBA
10/2017 - 04/2003
6HLA Antigens (Human Leukocyte Antigens)IBA
06/2011 - 04/2002
5HLA-DR4 Antigen (HLA DR4 Antigen)IBA
01/2014 - 10/2003
5Proteins (Proteins, Gene)FDA Link
02/2012 - 08/2002
5GliadinIBA
02/2012 - 12/2005
5AutoantibodiesIBA
08/2010 - 01/2007
5HLA-DQ Antigens (HLA-DQ)IBA
01/2010 - 01/2002
4staphylococcal enterotoxin BIBA
10/2017 - 11/2004
4Glutens (Glutelin)IBA
02/2012 - 11/2002
4AutoantigensIBA
12/2008 - 05/2002
4Thyrotropin Receptors (Thyrotropin Receptor)IBA
10/2007 - 09/2003
3Immunoglobulin G (IgG)IBA
10/2017 - 02/2003
3ExotoxinsIBA
12/2015 - 02/2007
3Histocompatibility Antigens Class IIIBA
01/2014 - 06/2004
3Capsid Proteins (Capsid Protein)IBA
09/2011 - 08/2002
3T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
09/2011 - 06/2004
3Collagen Type II (Type II Collagen)IBA
06/2011 - 10/2003
3HLA-DRB1*03:01 antigenIBA
12/2008 - 07/2007
3HLA-DRB1 Chains (HLA DRB1)IBA
09/2007 - 10/2004
2HLA-DR2 Antigen (HLA DR2 Antigen)IBA
11/2015 - 09/2007
2HLA-DRB1*04:02 antigenIBA
11/2014 - 10/2003
2HLA-DRB1*04:01 antigenIBA
11/2014 - 08/2008
2LipopolysaccharidesIBA
11/2014 - 06/2010
2EnzymesIBA
06/2014 - 12/2005
2HLA-DQ6 antigenIBA
01/2014 - 01/2002
2ArrestinIBA
08/2011 - 04/2003
2Retinaldehyde (Retinal)IBA
08/2011 - 04/2003
2HLA-DQB1 antigen (HLA DQB1)IBA
09/2009 - 12/2005
2DNA (Deoxyribonucleic Acid)IBA
12/2006 - 09/2003
2Myelin-Oligodendrocyte GlycoproteinIBA
12/2005 - 04/2003
2Messenger RNA (mRNA)IBA
11/2005 - 04/2005
2Immunoglobulin E (IgE)IBA
11/2005 - 02/2003
2AllergensIBA
02/2003 - 02/2003
1Bacterial Proteins (Bacterial Protein)IBA
10/2017
1Linezolid (Zyvox)FDA Link
10/2017
1Immunoglobulin Fc FragmentsIBA
10/2017
12,6-dinitrotoluene (DNT)IBA
01/2017
1Arginine (L-Arginine)FDA Link
02/2016
1Staphylococcal enterotoxin FIBA
06/2014
1Enterotoxins (Enterotoxin)IBA
06/2014
1ImmunosorbentsIBA
06/2014
1Lipoproteins (Lipoprotein)IBA
01/2014
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2014
1Peptidoglycan (Murein)IBA
01/2014
1lipoteichoic acidIBA
01/2014
1Myelin Proteolipid ProteinIBA
02/2012
1Myelin Basic ProteinIBA
02/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2012
1poly(hydroxyethyl methacrylate-co-styrene sulfonate)IBA
02/2012
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2012
1HLA-D AntigensIBA
11/2011
1Protein Glutamine gamma Glutamyltransferase 2IBA
10/2011
1Biomarkers (Surrogate Marker)IBA
08/2011

Therapy/Procedure

3Immunotherapy
10/2007 - 02/2003
2Therapeutics
10/2017 - 08/2002
1Catheters
08/2015
1Oral Administration
02/2012